Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Advancements in Clinicopathologic Assessment and Prognostication of Breast Ductal Carcinoma-in-Situ (DCIS)
*Corresponding Author:Received Date: Feb 01, 2024 / Published Date: Feb 27, 2024
Copyright: © 2024 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Breast ductal carcinoma-in-situ (DCIS) represents a critical stage in the spectrum of breast cancer, characterized by abnormal cell growth confined within the breast ducts. Although DCIS is non-invasive by definition, it has the potential to progress to invasive breast cancer if left untreated, making accurate prognostication and treatment selection paramount in clinical management. Among the various treatment modalities available for DCIS, breastconserving surgery (BCS) has emerged as a standard approach, aimed at excising the tumor while preserving the breast. However, the optimal management strategy post BCS hinges on a comprehensive evaluation of clinicopathologic features that can predict the risk of disease recurrence and guide therapeutic decisions.
